Clin2
NCT07448376Possibly a fitNot yet recruiting

Predicting pancreatic cancer spread with endoscopic ultrasound

CTCsPancreatic CancerLiver MetastasesRelapseBorderline Resectable Pancreatic CancerResectable Pancreatic CancersEUS

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This trial uses a special ultrasound test to collect cells from a pancreatic tumor and study them to better predict if the cancer may come back or spread. It aims to help doctors choose the best treatment plan for each person.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You have a solid mass in the pancreas larger than 1 cm that needs a biopsy to check if it's cancer.
  • You have been diagnosed with pancreatic cancer that is either removable by surgery, borderline removable, or locally advanced (has not spread far).
  • You are newly diagnosed and have not had chemotherapy or radiation therapy yet.
  • You are willing and able to follow the study procedures and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07418164Not yet recruiting
Endoscopic ultrasound for pancreatic and periampullary tumors

This study looks at how doctors use endoscopic ultrasound (EUS) to diagnose and manage tumors in the pancreas and nearby areas. If you have such a tumor, this study may help improve how these conditions are treated.

Bergamo
NCT05723107Recruiting· Phase 1
Testing an endoscopic treatment for pancreatic cancer that can't be removed

This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).

New York, New York
NCT06655233Recruiting
Exploring gut bacteria in pancreatic cancer tumors

This trial studies bacteria found inside pancreatic tumors to see if they can help diagnose or predict the course of the disease. You may be eligible if you have a suspected pancreatic cancer and need a special biopsy (EUS-FNB).

Hunan, Hunan
NCT06276738Not yet recruiting
Ultrasound imaging for suspected pancreatic cancer

This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.

NCT05196334Recruiting
Testing pancreatic lab samples to guide future treatments

This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.

Herlev, Copenhagen
NCT05195281Recruiting
Study changes in pancreatic cancer during treatment

This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.

Milan

Hear when a new Pancreatic cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.